 |
|
Tools and Resources
Androstenedione
| General Info |
|
Active Forms
Androstenedione (Androstene, Adriol), 4-Androstenediol (4-AD, Androdiol), 5-Androstenediol (5-AD, 5-Androdiol), Norandrostenediol (Norandrostene), 19-Norandrostenedione (19-Nordione), 19-Nor-androstenediol (19-Nordiol).
Absorption
Androstenedione appears to be well absorbed, but studies are insufficient to be conclusive about the rate of absorption of androstenedione.
Dietary Sources
Androstenedione is found in insufficient quantities in dietary sources to produce clinical effects.
|
 |
| Dosage Info |
Back to Top |
Dosage Range 25-900mg daily.
Most Common Dosage 50-100mg daily.
Dosage Forms Sublingual spray, sublingual tablets, capsules, transdermal cream, gel, and liposomal spray.
|
 |
Adult RDI None established
Adult ODA None established
|
 |
RDA
None established
|
| |
|
 |
| Overview |
Back to Top |
Editor's Note: While peer-reviewed scientific studies on this dietary supplement are lacking, many practitioners and individuals report observational and anectodal benefits from its use. The use of this dietary supplement is on the rise. For this reason, Intramedicine has provided this monograph using the information that is currently available. As more science-based research becomes available, this monograph will be updated to include that material.
|
Androstenedione is a weak androgenic steroid hormone produced naturally in the testes and adrenal cortex of men and in the ovaries and adrenal cortex of women. Androstenedione is an intermediate metabolite and direct precursor in the conversion of dehydroepiandrosterone (DHEA) to testosterone, estradiol and estrone. Natural production of testosterone is highly regulated by the body. Theoretically, oral androstenedione could subvert normal control mechanisms, resulting in transient increased testosterone levels. Androstenedione does not increase natural testosterone production. Various reports suggest that androstenedione increases testosterone levels anywhere from 0 to over 300 percent. Reported increases in testosterone levels from androstenedione supplementation are transient, beginning about 15 minutes after ingestion and peaking about 1-1½ hours later. Levels may remain elevated for as long as 3 hours. This transient elevation may not produce adverse effects of testosterone elevations, since it is not long enough to induce pituitary response. With limited use of androstenedione (small doses not exceeding 100mg taken just prior to heavy physical exertion), testosterone suppression is unlikely to occur. Androstenedione doses of 300mg daily have been demonstrated to result in significant increases of DHT, estradiol and estrone.(1) The National Football League, International Olympic Committee, National Collegiate Athletic Association and International Tennis have banned androstenedione in professional sporting events. The FDA does not regulate androstenedione and it is legal for OTC purchase. However, androstenedione is considered unsafe by many in the medical community. NOTE: All of the steroid hormones mentioned are isomers of androstene and are currently available on the market as supplements. There are three (3) different enzyme conversion pathways resulting in the utilization of these substances as precursors to testosterone hormones. All three result in a conversion to testosterone or nandrolone. NOT ALL FORMS PRODUCE THE SAME RESULTS. Each has different conversion pathways resulting in a variety of chemical compounds potentially with profoundly differing biochemical influences and side effects.(2) Conversion of androstenedione to estrogen in males increases in relationship to the levels of adipose tissue. Higher fat-to-muscle ratios result in increased levels of estrogen from androstenedione.(3) |
 |
| Toxicities & Precautions |
Back to Top |
Androstenedione appears to be well absorbed, but studies are insufficient to be conclusive about the rate of absorption of androstenedione.
General Supplementation of androstene and its isomers has not been widely studied in humans and some controversy exists over both the efficacy and potential toxicity of androstenediol supplementation.(4)
Large doses of androstenedione may convert to testosterone causing a similar side effect profile.(5)
Health Conditions Androstenedione should not be used by anyone with breast or prostate cancer, cardiac or renal compromise, hypercalcemia or impaired liver function.(6, 7)
Side Effects
The literature reports one case of a man who experienced 2 episodes of priapism (abnormal, painful, and continued erection of the penis in the absence of sexual desire) after taking androstenedione.(8)
Pregnancy/Breast-Feeding Androstenedione should not be used by pregnant or breastfeeding women.
Age Limitations Androstenedione is generally not recommended for women due to the potential for virilization, however, supplements that convert to nandrolone (norandrostene, norandrodiol), rather than testosterone, are likely to be more efficiently utilized in women. Androstenedione is not recommended for anyone under the age of 25, unless supervised by a physician. Men over the age of 45 should have frequent (every 6 months) PSA testing when using androstenedione.
|
 |
| Functions in the Body |
Back to Top |
Androstenedione has no known biological functions other than the role it plays as a precursor to testosterone and estrogens. When given to healthy men, orally administered androstenedione can produce increased levels of serum testosterone and estradiol.(9)
|
 |
| Clinical Applications |
Back to Top |
Enhancement Of Sports Performance Studies are not conclusive regarding the effectiveness of androstenedione to enhance performance and/or strength and there is some controversy over safety and effectiveness.(10)The conclusions of the authors of a recent study are contradictory.(11) |
Transient Testosterone Elevations Some studies have reported that oral supplementation with androstenedione produce significant increases in testosterone(12, 13) while others have reported negative outcomes.(14, 15) |
 |
| Symptoms & Causes of Deficiency |
|
|
No specific condition has been identified with a deficiency of androstenedione. Deficiency symptoms are indistinguishable from estrogen and testosterone deficiency symptoms.
|
 |
| Footnotes |
Back to Top |
1 King DS, Sharp RL, Vukovich MD, et al. Effect of Oral Androstenedione on Serum Testosterone and Adaptations to Resistance Training in Young Men: A Randomized Controlled Trial. JAMA. Jun1999;281(21):2020-28.
View Abstract
2 Huynh PN, Loria RM. Contrasting Effects of Alpha- and Beta-androstenediol on Oncogenic Myeloid Cell Lines in Vitro. J Leukocyte Biol. 1997;62:258-67.
View Abstract
3 Kley HK, Deselaers T, et al. Enhanced Conversion of Androstenedione to Estrogens in Obese Males. J Clin Endocrinol Metab. 1980;51(5):1128-32.
View Abstract
4 Yesalis CE 3rd. Medical, Legal, and Societal Implications of Androstenedione Use. JAMA. Jun1999;281(21):2043-44.
5 Luu-The V, et al. Type 5 17beta-hydroxysteroid dehydrogenase: its role in the formation of androgens in women. Mol Cell Endocrinol. Jan2001;171(1-2):77-82.
View Abstract
6 Blue JG, Lombardo JA. Steroids and steroid-like compounds.
Clin Sports Med. Jul1999;18(3):667-89.
View Abstract
7 Virilon-IM (testosterone cypionate injection), Product Prescribing Information. Star Pharmaceuticals, Inc. Pompano Beach, Florida; 2000.
8 Kachhi PN, Henderson SO. Priapism after androstenedione intake for athletic performance enhancement. Ann Emerg Med. Apr2000;35(4):391-3.
View Abstract
9 Leder BZ, Longcope C, Catlin DH, et al. Oral androstenedione administration and serum testosterone concentrations in young men. JAMA. Feb2000;283(6):779-82.
View Abstract
10 Apgar B. Do 'Health Products' Really Help Athletic Performance? Am Fam Physician. Apr1999;59(7):1990,1992.
11 King DS, Sharp RL, Vukovich MD, et al. Effect of Oral Androstenedione on Serum Testosterone and Adaptations to Resistance Training in Young Men: A Randomized Controlled Trial. JAMA. Jun1999;281(21):2020-28.
View Abstract
12 Earnest CP, Olson MA, Beckham SG, et al. Oral 4-androstene-3,17-dione and 4-androstene-3,17-diol Supplementation in Young Males. JPEN. 1999;23(1):816.
13 Leder BZ, Leblanc KM, Longcope C, Lee H, Catlin DH, Finkelstein JS. Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women. J Clin Endocrinol Metab. Dec2002;87(12):5449-54.
View Abstract
14 King DS, et al. Effect of Oral Androstenedione on Serum Testosterone and Adaptations to Resistance Training in Young Men: A Randomized Controlled Trial. JAMA. Jun1999;281(21):2020-28.
View Abstract
15 Rasmussen BB, Volpi E, Gore DC, Wolfe RR. Androstenedione does not stimulate muscle protein anabolism in young healthy men. J Clin Endocrinol Metab. Jan2000;85(1):55-9.
View Abstract
|
|
 |